Fox News medical contributor Dr. Nicole Saphier joins 'Fox & Friends Weekend' to discuss a male birth control study and the side effects of women's birth control.

A first-of-its-kind male birth control pill just cleared its first human safety test, raising hopes that it could soon open the door to a new era of contraception.

Service and patient care workers will go on strike Friday at the University of California, San Francisco Medical Center to protest the university's decision to lay off more than 130 frontline ...

A popular method of birth control has been linked to the development of a specific type of brain tumor in multiple studies — and patients are now suing the manufacturer.

Earlier this year, the Trump administration scrubbed CDC guidance on birth control from government websites and froze $65 million in funding to family planning clinics that provide free or low ...

But scientists are working on an alternative approach that might be more appealing for some: a non-hormonal male birth control pill with possibly very few side effects.

Experimental hormone-free male birth control pill shows promise in human safety trial with no serious side effects.

Policy over people: U.S. to burn $9.7M in birth control Critics say policy conflates abortion and birth control; aid groups say supplies could have helped 650,000 people ...

Scientists May Have Created the First Male Birth Control Pill Without Side Effects The effects of the drug are completely reversible after six weeks of cessation. And still with no side effects!

The Trump administration is literally torching nearly $10 million worth of birth control meant for women in countries where they cannot access or afford it.

YourChoice Therapeutics, working with Quotient Sciences and Incyte, reports that single oral doses of the investigational non‑hormonal male contraceptive YCT‑529 up to 180 mg produced no ...

A hormone-free pill, called YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite has just concluded its first safety trial in humans, getting a step closer to ...